Literature DB >> 8811311

Toxicity of chemotherapy.

R M Lowenthal1, K Eaton.   

Abstract

Because anticancer drugs are cytotoxic for normal as well as neoplastic cells, the range of unwanted effects that accompanies their use is broad. Many of the side effects are potentially life-threatening or seriously debilitating. Many are similar to, and readily confused with, direct or indirect (paraneoplastic) consequences of the cancer itself. Recognition of drug side effects is vital for optimal patient care, because early withdrawal of the offending agent and institution of appropriate treatment have the potential to significantly reduce the overall morbidity and mortality associated with the diagnosis of cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811311     DOI: 10.1016/s0889-8588(05)70378-6

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  13 in total

Review 1.  Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.

Authors:  K Hoekman; W J van der Vijgh; J B Vermorken
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

Review 2.  Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.

Authors:  Anthony L Kovac
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent.

Authors:  Mi Kyung Kwak; Keun Hur; Ji Eun Yu; Tae Su Han; Kazuyoshi Yanagihara; Woo Ho Kim; Sun Mi Lee; Soo-Chang Song; Han-Kwang Yang
Journal:  Invest New Drugs       Date:  2009-04-22       Impact factor: 3.850

Review 4.  Factors influencing the choice of 5-HT3-receptor antagonist antiemetics: focus on elderly cancer patients.

Authors:  Cesare Gridelli; Matti Aapro
Journal:  Support Care Cancer       Date:  2004-03-04       Impact factor: 3.603

5.  Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.

Authors:  Sachin Mittal; Xueqin Song; Balvinder S Vig; Gordon L Amidon
Journal:  Pharm Res       Date:  2007-03-22       Impact factor: 4.580

Review 6.  Nonclonal Chromosome Aberrations and Genome Chaos in Somatic and Germ Cells from Patients and Survivors of Hodgkin Lymphoma.

Authors:  Sara Frias; Sandra Ramos; Consuelo Salas; Bertha Molina; Silvia Sánchez; Roberto Rivera-Luna
Journal:  Genes (Basel)       Date:  2019-01-10       Impact factor: 4.096

7.  A Study of the Effects of Doxorubicin-Containing Liposomes on Osteogenesis of 3D Stem Cell Spheroids Derived from Gingiva.

Authors:  Hyunjin Lee; Jihwan Son; Sae Kyung Min; Chae-Bin Na; Gawon Yi; Heebeom Koo; Jun-Beom Park
Journal:  Materials (Basel)       Date:  2019-08-23       Impact factor: 3.623

8.  Glutathione Transferase (GST)-Activated Prodrugs.

Authors:  Paolo Ruzza; Andrea Calderan
Journal:  Pharmaceutics       Date:  2013-04-02       Impact factor: 6.321

Review 9.  Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field.

Authors:  Fernanda Andrade; Maria Mercé Roca-Melendres; Esteban F Durán-Lara; Diana Rafael; Simó Schwartz
Journal:  Cancers (Basel)       Date:  2021-03-09       Impact factor: 6.639

10.  Modulation of intrinsic inhibitory checkpoints using nano-carriers to unleash NK cell activity.

Authors:  Guy Biber; Batel Sabag; Anat Raiff; Aviad Ben-Shmuel; Abhishek Puthenveetil; Jennifer I C Benichou; Tammir Jubany; Moria Levy; Shiran Killner; Mira Barda-Saad
Journal:  EMBO Mol Med       Date:  2021-11-02       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.